Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Collectively declared rate
4.04%
Threshold
Crossed upwards
Timeline
Published
28.08.2008
Transaction
15.07.2008
Transfer date
15.07.2008
Voting rights breakdown
Voting rights acquired4.04%
Voting rights sold0%
Below threshold0%
Declared beneficial owners · 2
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
T6488D6243
Beneficial owner
Heidelberg Innovation BioScience Venture II GmbH & Co. KG
Declared address
Heidelberg Innovation BioScience Venture II GmbH & Co. KG, Heidelberg
Die Heidelberg Innovation GmbH BioScience KG tritt aus der Gruppe aus.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open